In AD skin, IL-4 and IL-13 contribute to skin barrier impairment, reducing the expression of terminal differentiation proteins such as FLG, LOR, and involucrin (INV) in both lesional and nonlesional skin [68, 69]. This evidence concerns the gene IL13 and Alzheimer disease.